Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Sara Ebrahimi
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation with Concomitant Tricuspid Regurgitation
2000
Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment
10.1093/eurheartj/ehae088 · 2024
Incidence and Burden of Tricuspid Regurgitation in Patients With Atrial Fibrillation
10.1016/j.jacc.2022.09.045 · 2022
Improvement in tricuspid regurgitation following catheter ablation of atrial fibrillation
10.1111/jce.14707 · 2020
Long-term outcome of catheter ablation in patients with persistent atrial fibrillation and functional tricuspid regurgitation
10.3389/fcvm.2025.1600238 · 2025
Effectiveness of Rhythm Control of Atrial Fibrillation in Moderate-to-Severe or Severe Secondary Tricuspid Regurgitation
10.1016/j.jcmg.2026.03.006 · 2026
Improvement of functional mitral and tricuspid regurgitation in patients with atrial fibrillation after sinus rhythm restoration-the Berlin FMTR registry
2026
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
10.1093/eurheartj/ehae176 · 2024
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
10.1056/nejmoa2019422 · 2020
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial
10.1001/jama.2019.0693 · 2019
No additional external references are available.